Do You Know the Most Important and Timely Stock Plays During the Trading Week? View Our Power Rankings.
anonusers Placed a 'Sell' Sentiment on UNVC1 day ago
anonusers Placed a 'Buy' Sentiment on HOME3 days ago
anonusers Placed a 'Sell' Sentiment on WBA3 days ago
russurban Placed a 'Buy' Sentiment on VXRT3 days ago
russurban Placed a 'Buy' Sentiment on OTLK3 days ago
russurban Followed OTLK3 days ago
stockarticles Placed a 'Buy' Sentiment on BB3 days ago
stockarticles Followed BB3 days ago
stockarticles Placed a 'Buy' Sentiment on SNAPMore than a week ago
Most Discussed Stocks through Posts and Reactions on SpeculatingStocks  VXRT  •  OTLK  •  PINS  •  BB  •  TWTR  •  CGC  •  ARCI  •  LULU  •  SNAP  •  IRBT

March 5, 2015 Stock Pick: Acura Pharmaceuticals, Inc. (ACUR)

Stock Price: $0.74

Acura Pharmaceuticals, Inc. is a speciality pharmaceutical company, in the business of researching, developing, and commercializing products to address medication abuse and misuse utilizing its proprietary Aversion and Impede technologies.

ACUR has products which include 1) Oxecta tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; 2) Nexafed, a pseudoephedrine HCl tablet that is used as a nasal decongestant in various non-prescription and prescription cold, sinus, and allergy products and 3) seven additional opioid products.

ACUR has some interesting technology known as NEXAFED® Sinus Pressure + Pain [pseudoephedrine HCI 30mg + acetaminophen 325mg], a meth-resistant immediate-release tablet. NEXAFED Sinus Pressure + Pain will continue to utilize NEXAFED's unique, patented IMPEDE® technology that disrupts the conversion of PSE into the dangerous drug methamphetamine (meth), and will be the first meth-resistant PSE combination sinus medicine available. 

ACUR's patented technology holds a lot of potential to recieve greater adoption. Right now, ACUR is trading at a market cap of only $36.22 million. The company was recently upgraded by from a "Hold" to "Buy" from MLV & Co.

ACUR recently climbed from $0.50 to as high as $1.15 and recently filled its Feb. 27th gap higher. It looks like ACUR is at a great point in its chart with significantly increased volume interest the past 5 trading days.

Speculative Score: 8

1 Being the Least Speculative and Most Confident

10 Being the Most Speculative and Possibly the Most Risky


Untitled Document